The Discriminative Stimulus Properties of Morphine and U-50,488H in a Three-Key Assay: A MU and Kappa Opioid Discrimination in t
Understanding opioids in veterinary medicine
μ Opioid receptor: novel antagonists and structural modeling | Scientific Reports
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics
The role of the opioid system in decision making and cognitive control: A review | SpringerLink
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Morphine | C17H19NO3 - PubChem
Opioids Lecture II. - ppt download
America's Long-Overdue Opioid Revolution Is Finally Here | Science| Smithsonian Magazine
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
NorBNI and morphine induce ROS production via JNK and PRDX6. MycKOR a,... | Download Scientific Diagram
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Opioid Tolerance–In Search of the Holy Grail: Cell
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity | Journal of Medicinal Chemistry
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
